We're developing innovative treatments for Alzheimer's disease.

Our Science


Screening Platform
Excavation of new drug candidate based on screening platform
Misfolded Protein
Disaggregators and clearance enhancers will help eliminate the toxic amyloid-β and Tau
Accumulation of neurotoxic proteins, amyloid-β and tau, is a unique event of Alzheimer's disease.
We have faith that reversing and/or eliminating this abnormality is the key approach to end the fatal neurodegeneration.
Controlling the immune system in the brain will have the potential to treat Alzheimer's disease
Our first-in-class drug candidates rescue abnormal glia, impaired by amyloid-β and tau, in Alzheimer’s brain to its normal state.